Entry price: 32.66
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 157%
- EPS % Chg (Previous Qtr): -68%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 354%
- Sales % Chg (Previous Qtr): 38%
- 3-Year Sales Growth Rate: 167%
- Annual Pre -Tax Margin: -249.8%
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 157%
- EPS % Chg (Previous Qtr): -68%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 354%
- Sales % Chg (Previous Qtr): 38%
- 3-Year Sales Growth Rate: 167%
- Annual Pre -Tax Margin: -249.8%
Comment:
--------------------------------
EPS % Chg (Last Qtr): 14%
Sales % Chg (Last Qtr): 164%
EPS % Chg (Last Qtr): 14%
Sales % Chg (Last Qtr): 164%
Comment:
Sold at 74.50
Return: +134.95%
Return: +134.95%
Comment:
Average price: 31.71